Edge Therapeutics (EDGE) Reports Q3 Loss of $7.08
Tweet
Share
E-mailGet Alerts EDGE Hot Sheet
Join SI Premium – FREE
Edge Therapeutics (NASDAQ: EDGE) reported Q3 EPS of ($7.08), versus ($2.30) reported last year.
For earnings history and earnings-related data on Edge Therapeutics (EDGE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Jefferies Downgrades Belimo Holding AG (BEAN:SW) (BLHWF) to Hold
- Goldman Sachs Starts Chagee Holdings (CHA) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
